ID: ALA5289699

Max Phase: Preclinical

Molecular Formula: C18H11N3

Molecular Weight: 269.31

Associated Items:

Representations

Canonical SMILES:  c1ccc2c(c1)Nc1nc3ccccc3c3ccnc-2c13

Standard InChI:  InChI=1S/C18H11N3/c1-3-7-14-11(5-1)12-9-10-19-17-13-6-2-4-8-15(13)21-18(20-14)16(12)17/h1-10H,(H,20,21)

Standard InChI Key:  HMTOGOKFHJKDBP-UHFFFAOYSA-N

Associated Targets(Human)

Aryl hydrocarbon receptor 1071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 269.31Molecular Weight (Monoisotopic): 269.0953AlogP: 4.51#Rotatable Bonds: 0
Polar Surface Area: 37.81Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.30CX LogP: 4.00CX LogD: 4.00
Aromatic Rings: 4Heavy Atoms: 21QED Weighted: 0.42Np Likeness Score: -0.04

References

1. Lin L, Dai Y, Xia Y..  (2022)  An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002-2022): A medicinal chemistry perspective.,  244  [PMID:36274276] [10.1016/j.ejmech.2022.114845]

Source